TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
21 hedge funds and large institutions have $2.1M invested in Titan Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
21
Holding in Top 10
–
Calls
$66K
Puts
–
Top Buyers
| 1 | +$193K | |
| 2 | +$24.9K | |
| 3 | +$12.4K | |
| 4 |
BlackRock
New York
|
+$6.22K |
Top Sellers
| 1 | -$531K | |
| 2 | -$168K | |
| 3 | -$162K | |
| 4 |
D.E. Shaw & Co
New York
|
-$63K |
| 5 |
GS
Gagnon Securities
New York
|
-$61K |